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Rickettsia felis, the causative agent of flea-borne spotted fever, is an emerging pathogen 
of the transitional group Rickettsiae and an important cause of febrile illness in Africa. Since the 
organism’s original discovery in the early 1990s, much research has been directed towards 
elucidating transmission mechanisms within the believed primary host and reservoir, the cat flea 
(Ctenocephalides felis). However, while a growing number of human cases are being reported 
throughout the world, a definitive transmission mechanism from arthropod host to vertebrate 
host resulting in clinical disease has not been found. Several possible mechanisms, including bite 
of infected arthropods and association with infectious arthropod feces, are currently being 
investigated. This current study was undertaken to examine the role of infectious cat flea feces in 
dissemination of the organism to vertebrates. It was hypothesized that if cat fleas excrete viable 
R. felis during feeding, then the feces are capable of producing infection in vertebrates through 
cutaneous inoculation. Feces of cat fleas infected with R. felis were analyzed for the presence of 
the organism, and these potentially infectious feces were then used to intradermally inoculate 
naïve BALB/c mice. The results of this research show that R. felis is present in high numbers in 
infected cat flea feces post-exposure to an infectious blood meal, and these bacteria are presumed 
viable due to the detection of rickettsial transcripts within the feces. Detectable amounts of R. 
felis were found in the skin of mice inoculated both with R. felis from culture and R. felis-
infected flea feces, and rare animals injected with R. felis from culture showed possible systemic 
dissemination. The response of mice inoculated with R. felis-infected cat flea feces is primarily a 
neutrophilic dermatitis with positive anti-Rickettsia IgG titers at 14 days post-exposure. No mice 
developed any overt clinical or physical signs. This study demonstrates that cutaneous 
inoculation with infectious arthropod feces is an effective transmission medium for the organism 
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to mice. Further work is needed to define the role of this route of exposure in the epidemiology 
of the human disease.  
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CHAPTER 1: RICKETTSIA FELIS: A REVIEW OF TRANSMISSION MECHANISMS 
OF AN EMERGING PATHOGEN1 
1.1. Introduction 
Rickettsia felis, an obligate intracellular bacterium of the transitional group Rickettsia, is 
the causative agent of emerging flea-borne spotted fever [1]. This organism was first associated 
with human disease in a patient from Texas in 1994 [2], and human cases have since been 
reported on every continent except for Antarctica [3]. The widespread nature of the disease is 
likely secondary to the believed primary vector and reservoir host, the cat flea (Ctenocephalides 
felis), which shares a similar pervasive range (Figure 1). While much work has been done to 
investigate the spread of R. felis between cat fleas and to vertebrate hosts, a definitive 
transmission mechanism that produces a rickettsemic host with clinical signs that mimic the 
human disease has yet to be found. 
Recent studies have associated R. felis to infection and febrile illness in Africa, with up to 
15% of patients with fever of unknown origin having detectable levels of R. felis in their blood 
via PCR analysis [4]. There have also been recent outbreaks of flea-borne ricketssiosis in the 
United States, including Texas, California, and Hawaii, where data has shown R. felis to be more 
prevalent in arthropods and mammals via PCR analysis in the area than R. typhi (the etiologic 
agent of murine typhus) [5-7]. Murine typhus is another flea-borne rickettsioses, of the typhus 
group Rickettsia, causing a disease clinically indistinguishable from R. felis. This agent also has 
endemic foci in southern California and south Texas [4]. Given the similarities in clinical 
presentations and location of outbreaks, it is evident how many of these cases could be confused 
                                                





with each other, as well as other similar rickettsial diseases. The advent of more sophisticated 
diagnostic techniques has aided in the distinction of some of these cases [8], allowing for a 
clearer clinical picture of flea-borne spotted fever. 
Figure 1. Reported distribution of R. felis in the world. 
R. felis-positive arthropods have been reported in (blue): Afghanistan, Albania, Algeria, Argentina, 
Australia, Canada, Chile, Colombia, Croatia, Cyprus, Czech Republic, Democratic Republic of 
Congo, Ethiopia, Gabon, India, Indonesia, Israel, Italy, Ivory Coast, Japan, Lebanon, Malaysia, 
Morocco, Panama, Peru, Portugal, Romania, United Kingdom, and Uruguay. Along with infected 
arthropods, human cases of R. felis have been reported in (red): Australia, Brazil, China, France, 
Germany, Kenya, Laos, Mexico, New Zealand, South Korea, Spain, Taiwan, Thailand, Tunisia, and 
the United States. Human cases without detection of infected arthropods have been reported in 




Rickettsiosis is caused by bacteria of the genus Rickettsia, which includes the spotted 
fever group (SFG), typhus group (TG) and, a more recent classification, transitional group 
(TRG) [9]. Rickettsia spp. are most commonly divided into the SGF or TG based on their vector 
of transmission,  antigenic characteristics, optimal growth temperatures, percent G+C DNA 
contents, and clinical features [10]. Bacteria associated with the SFG are usually transmitted to 
vertebrates via the bites of hard ticks, while members of the TG are predominantly transmitted 
by contamination of mucous membranes, conjunctivae, and/or open wounds with the infectious 
feces of lice and fleas [11]. Rickettsia felis was originally charactized as a typhus-like Rickettsia 
due to the fact that the first human case was originally misdiagnosed as murine typhus and the 
organism was initially isolated from a laboratory flea colony. Additionally, early analysis of the 
17-kDA and citrate synthase genes of R. felis supported a TG classification [12]. However, later 
analysis revealed the presence of the ompA gene and a 17-kDA gene having more similarity to 
the SFG rather than TG [1]. There has been some debate in the literature as whether to classify R. 
felis as TRG Rickettsia or a SFG variant. While some agree with the creation of a third group of 
Rickettsia spp. (TRG), others still classify R. felis as a SFG Rickettsia sp. The latter classification 
for R. felis as a SFG-variant coincides with other organisms that also are transmitted by 
arthropods other than ticks (e.g. R. felis-like organisms and R. hoostraalii) [11]. The difficulty in 
even classifying this emerging pathogen helps display part of the obstacles that many have had in 
distinguishing R. felis from other related bacteria in both clinical and laboratory settings.  
1.3. Clinical Disease 
The clinical manifestation of several rickettsioses, specifically R. felis and R. typhi, have 
many similarities, including headache, chills, fever, myalgia, and malaise, with a large number of 
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patients presenting with a maculopapular rash [4].  Few cases have presented with an “eschar,” 
which is a single crusted, cutaneous lesion surrounded by a halo, thought to represent the site of 
inoculation via an arthropod [13]. It has been reported that the percentage of patients that present 
with rashes and eschars (75% and 13%, respectively) is higher in cases of R. felis compared to R. 
typhi [4]. Rarely, R. felis has also been associated with neurologic signs (including a 
polyneuropathy-like syndrome and subacute meningitis), pneumonia, and gastrointestinal 
symptoms [14]. To date, there have been no reports of R. felis causing more serious 
complications or death [1]. However, the similarity of flea-borne spotted fever symptoms to R. 
typhi and other vector-borne diseases, as well as the lack of specific diagnostics, has potentially 
led to an underdiagnosis of R. felis in many human cases. 
As stated previously, R. felis has been reported as an emerging cause of fever of unknown 
origin in Africa. However, given the fact that R. felis has also been detected in skin swabs from 
afebrile patients in Africa [15], it has been suggested that the organism is ubiquitous in the area 
and its true pathogenecity has been questioned [16]. To explain the variable presentations, it has 
been proposed that patients in Africa exhibit a more chronic form of the disease, with disease-
free intervals interspersed with periods of relapse (similar to malaria- which shares a common 
epidemiology to R. felis in certain areas of Africa) [14]. Adding to the perplexing nature of R. 
felis in Africa, several studies performed in areas of outbreaks have surprisingly not been able to 
detect R. felis in local cat fleas [14]. The organism was, however, able to be detected in multiple 
species of mosquitoes, including several Anopheles spp. Survey studies in the area have shown a 
correlation between the locations R. felis-infected mosquitoes and human infections [17], as well 
as a correlation between infected mosquitoes and prevelance of R. felis in ape feces [18], 
suggesting a potential role for alternate hosts in the disease ecology in Africa. 
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One of the strongest correlations between R. felis and human disease in Africa came from 
a recent case study that described a vesicular fever in an 8-month old girl in Senegal [15]. The 
patient erupted in vesicles and ulcers over her entire body and presented with a fever. Swabs 
were performed of the cutaneous lesions, which were found to be qPCR-positive for R. felis, 
although qPCR results were negative in the blood samples. Additionally, sera samples collected 
from time points prior to infection, as well 40-days post-presentation, were negative for R. felis 
antibodies via IFA and Western blot analysis. Given the lack of seroconversion of the patient, 
this was described as a primary infection of R. felis causing the clinical cutaneous presentation. 
Researchers proposed the term “yaaf” to idenfity the clinical entity, the Senegalese word for 
vesicle [15]. Another case of a primary infection was described previously in the Yucatan, with 
similar lesions, suggesting the specific cutaneous lesions may be pathognomonic for R. felis [19]. 
The inability to isolate R. felis from blood, even in acutely ill patients, has been thought to 
preclude a definitive link between the organism and disease. However, these recent case studies 
have shown that there is a possible alternative route to disease that does not include circulating 
blood-borne rickettisal organisms.  
1.4. Transmission to Arthropods 
To date, thirty-nine species of arthropods have been associated with R. felis, including 
several different species of fleas, ticks, lice, and mosquitoes [20]. However, the cat flea 
(Ctenocephalides felis) has been shown to serve as not only the primary vector, but seemingly 
the reservoir of R. felis in the environment as well [3, 21]. The maintenance of R. felis within 
laboratory colonies of cat fleas has been extensively studied and was originally attributed mainly 
to vertical transmission, or the transmission of pathogen from parent to offspring [12, 22]. Strong 
evidence for this mechanism was given when R. felis was found to be present in both male and 
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female cat flea reproductive tissue, including the ovaries and epithelial sheath of the testes [23].  
Rickettsia felis was first shown to undergo transovarial transmission, with detection of R. felis in 
freshly-deposited cat flea eggs [12], followed by the exhibition of R. felis in newly emerged 
unfed adult cat fleas, demonstrating transstradial transmission [24]. However, vertical 
transmission of R. felis to the progeny of cat fleas has reported to be highly variable, with several 
studies demonstrating the inability of cat fleas to maintain vertical transmission of R. felis when 
exposed as adults [22, 25, 26].  While observed variability in vertical maintenance is likely a 
laboratory artifact, this lack of transmission to progeny during infection bioassays suggests 
alternate mechanisms to introduce and maintain R. felis in vector populations likely exist.  
The ability to undergo frequent horizontal (infectious) transmission has been shown to be 
more prevelant in virulent rickettsiae species [27]. Multiple mechanisms for horizontal 
tranmission have been elucidated for R. felis within cat fleas, as well as other invertebrate hosts. 
A prerequisite to successful horizontal transmission is oral acquisition of R. felis. This was 
demonstrated by an experiment exposing unifected cat fleas to an R. felis-infected bloodmeal in 
an artificial host system, where cat fleas were shown not only to be able to acquire the the 
infection, but also remain persistently infected for up to 28 days post-exposure [22]. 
Demonstration of transmission through a shared blood meal was confirmed via an experiment 
where cat fleas, both infected and uninfected, fed on an artificial host. Uninfected cat fleas 
became infected with R. felis at varying rates (3.3-40.0%), as early as 24-hours post-exposure to 
infected fleas [26]. In this experiment, it was also shown that cat fleas could become infected 
through mating with infected cat fleas without exposure to any infectious bloodmeal. Cofeeding, 
which is the successful horizontal tranmission of pathogens between actively blood-feeding 
arthropods in the absence of a disseminated vertebrate infection, has also been demonstrated in 
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cat fleas infected with R. felis. Infected (donor) cat fleas were placed in either the same capsules 
(co-fed) or different capsules (cross-fed) as uninfected (recipient) cat fleas on an uninfected 
murine host. Recipient cat fleas were shown to acquire the infection in both co-fed and cross-fed 
models in absence of the murine hosts becoming rickettsemic. Interestingly, the experiment also 
revealed that infected cat fleas were able to transmit R. felis to naïve rat fleas (Xenopsylla 
cheopis) [3].  
There has been further investigation into the specific mechanism of horizontal 
transmission of R. felis between cat fleas. Support for salivary transmission was found when R. 
felis was detected via qPCR in the salivary gland of cat fleas that had been feeding on cats for 2-
4 days [28]. Definitive evidence for salivary gland localization within cat fleas was given when 
rickettsial organisms were visualized via IFA in salivary glands in previously uninfected cat fleas 
7-14 days post-exposure to an infectious blood meal [29].  Given these findings, as well as the 
previously discussed studies on co-feeding, there is strong evidence for R. felis transmission 
through infectious saliva in cat fleas (e.g. biological transmission).  Recent evidence for 
mechanical transmission has also been demonstrated in cat fleas. Previously uninfected cat fleas 
were shown to be infectious to naïve cat fleas as early as 24 hours post-exposure to an infectious 
blood meal, indicating early-phase transmission. In addition, R. felis was not able to be detected 
in the salivary glands of these infectious cat fleas and the organism was shown to be released 
from contaminated mouthparts during probing [30].  
While R. felis is primarily transmitted by C. felis, multiple field studies have 
demonstrated molecular detection of the infectious agent in not only other species of fleas, but 
also ticks, mites, and mosquitoes [13, 30].  However, it is unclear whether these other arthropods 
contribute to the ecology of R. felis, or if their R. felis-infection is transient and insignificant in 
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transmission [21]. Recently, ticks exposed to R. felis maintained rickettsiae for one generation, 
but transmission was not stable [31]. Likewise, Anopheles gambiae mosquitoes demonstrated the 
ability to sustain an infection for up to 15 days, but stable transmission was not observed [32]. 
Various genotypes of R. felis have also been isolated from several of these other non-flea 
arthropods [21], including a novel strain of R. felis that was identified in the non-blood-feeding 
booklouse, Liposcelis bostrychophila [33, 34]. This strain of R. felis (str. LSU-Lb) has been 
shown to have to ability to not only infect cat fleas, but also undergo vertical transmission within 
these arthropods as well [25]. Genetic variation was not only found between strains isolated from 
different hosts (e.g. cat flea vs. booklouse), but also from strains isolated from the same host at 
different geographic locations [27]. Interestingly, R. felis seems to have a different effect on the 
host depending on the vector. As stated previously, vertical transmission of R. felis in C. felis has 
been highly variable, suggesting that this organism has a negative fitness effect on the arthropod 
population, requiring additional horizontal tranmission for pathogen maintance. However, in the 
booklouse, R. felis has been shown to be maintained 100% transovarially, and clearance of the 
organism from adults actually resulted in decreased longevity, fecundity, and non-viable egg 
production [33, 35]. Given the variation reported within arthropods, further work investigating 
the effect of strain variation within various arthropod species must still be done.  
1.5. Transmission to Vertebrates 
While several transmission mechanisms within arthropods have been described in 
relation to infection with R. felis, the means by which vertebrates acquire an infection from these 
arthropods remains unclear. Transmission of flea-borne pathogens is often multifactorial, with 
each species having several transmission routes to ensure maintenance [20]. The most common 
route of flea-borne pathogen transmission to vertebrates is through the bite of an infected 
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arthropod. Evidence that this could be a possible infection route for R. felis in C. felis was given 
by demonstrating the organisms within the salivary glands of fleas [28, 29]. Further, naïve cats 
exposed to cat fleas infected with R. felis seroconverted after four months, and R. felis DNA was 
detected via qPCR in the blood of 5/16 of these cats [36]. However, definitive culture of the 
organism from the blood of exposed cats could not be obtained. A survey study that sampled 
over 100 cats from several states in the United States found none to have detectable levels of R. 
felis in the blood, however, one cat did have detectable levels on the skin and another on the 
gingiva [37]. The cutaneous presence of R. felis in one feline patient, combined with the lack of 
circulating organisms, is reminiscent of the cutaneous presentation of human patients in Africa 
and the Yucatan, although no cutaneous lesions were reported in the cat.  
Another possible mechanism for vertebrate infection is via infectious vector feces. 
Excretion of viable rickettsiae in feces of infected arthropods has been found to be crucial in the 
tranmission for other species, including Rickettsia prowazekii and Rickettsia typhi. The most 
common form of exposure to infectious arthropod feces is through cutaneous inoculation, either 
through the deposition of arthropod feces at the bite site or contamination of broken skin or 
wounds with feces. Transmission of R. prowazekii has been demonstrated to occur via 
scarification of a louse bite site with rickettsiae-laden feces [38], and cutaneous inoculation of 
feces from fleas infected with R. typhi has been shown to create infections in rat and man (with 
as little as 0.2 mg of flea feces producing infection) [39, 40]. A closely related bacteria, 
Bartonella hensalae, has also been shown to use this tranmission mechanism for dissemination 
to vertebrates. Feces from cat fleas infected with the bacterium caused cats to become bacteremic 
1-2 weeks post intradermal injection, as well as caused seroconversion by 20 weeks post-
injection [41].  
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There is evidence to suggest that R. felis is also transmitted via infectious flea feces. Egg-
free feces from R. felis-infected C. felis fleas was assessed at days 2-28 post-exposure to an 
infectious blood meal. R. felis gDNA was detected at most time points throughout the study via 
qPCR amplification of the 17-kDa gene. Additionally, there is evidence that these are viable, 
transcriptionally active rickettsial organisms because a R. felis transcript was detected in the 
feces at 21 days post-exposure to an infectious bloodmeal [22]. Further work with vertebrates 
must be performed to determine if this is a possible R. felis transmission mechanism in vivo.  
It is difficult to study transmission of R. felis to vertebrate hosts because a definitive host 
with appropriate clinical signs and bacteremia has not been found. Several animals, including 
cats, dogs, opossums, raccoons, rodents, and humans, have been found to be either seropositive 
or PCR-positive for R. felis DNA. Additionally, the cat flea lacks true host specificity, and R. 
felis-infected arthropods have been recovered from cats, dogs, rodents, opossum, hedgehogs, 
horses, sheep, goats, gerbils, and monkeys [30]. Given the lack of a definitive mammalian host, 
many research experiments have looked at transmission of R. felis from cat fleas to vertebrates 
using rodents, including mice and rats. Information about choice of mouse strain could be taken 
by previous experiments performed on related species, such as Rickettsia parkeri, a member of 
the SFG rickettsiae. Several strains of inbred mice, including A/J, BALB/c, C3H/HeJ, and 
C3H/HeN, were studied to determine their response to intravenous and intradermal inoculation 
of R. parkeri [42]. The only strain to show pathology consistent with sustained infection was 
C3H/HeN, which exhibited marked facial edema and splenomegaly, as well as characteristic 
eschar-like lesions. Given this information, the C3H/HeN strain was more extensively studied 
with regards to R. felis infection. Post-intravenous incoulation with a high-dose of R. felis (1x106 
organisms), C3H/Hen mice had detectable levels of rickettsial DNA in the spleen and liver as 
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early as 1 day post-inoculation. Levels decreased to 50% or less by 6- and 14-days post injection. 
Rickettsia felis DNA was never detected in the blood of the mice, and no mice exhibited any 
overt clinical signs of illness or pathology [Macaluso, Unpublished]. This mouse strain was also 
used in the previously described cofeeding experiment, where mice received an interdermal 
inoculation with 5x109 rickettsiae from culture. Mice in this study also did not show any 
evidence of clinical signs or R. felis DNA in their blood, although other organs including liver 
and spleen were not tested for presence of R. felis gDNA [3]. 
A recent study looked at another mouse strain, BALB/c, in regards to the ability to 
acquire an R. felis infection. This study actually utilized mosquitoes, Anopheles gambiae, to 
examine transmission to vertebrates. This approach was undertaken to further investigate the 
paradox of the low number of infected cat fleas found in areas of high R. felis prevalence in 
Africa. Natural bites from R. felis-infected A. gambiae mosquites were shown to produce a 
transient rickettsemia in BALB/c mice, confirmed via qPCR analysis of the blood [32]. The 
bacteremia was present in a majority of the mice both 1 and 2 days after being exposed to 
infected mosquitoes, but disappeared by day 3. However, even though this mouse model was 
able to acquire an infection, no clinical signs or physical changes were reported in these mice. 
While several of these mouse models have shown some promise, it is apparent that a definitive 
laboratory model that mimics the clinical disease in humans has yet to be found. 
1.6. Discussion 
It is clear that there is still much to be understood about Rickettsia felis. While the cat flea 
is still believed to be the primary reservoir and vector of the organism worldwide, the discovery 
of multiple arthropods that harbor the pathogen reveals the need to do more extensive field 
research, including analysis of all possible arthropods in the area of reported human disease. A 
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more complete picture of the possible vectors of human disease could propel research in the right 
direction. In addition, given that multiple transmission mechanisms within C. felis have been 
elucidated, it is possible that the transmission of R. felis within and amongst other arthropods is 
equally as complicated and multifactorial. Experiments that include transmission of the organism 
to multiple vectors might more closely mimic what is happening in nature. The most perplexing 
question that remains to be answered is how humans are acquiring the infection. While bites 
from infected cat fleas were previously thought to be the most likely mechanism, multiple 
laboratory experiments have not been able to produce a rickettsemic vertebrate with clinical 
signs that mimic a human infection through this route. It is important to note, given the findings 
in Africa of non-rickettsemic patients that exhibit clinical signs, an appropriate laboratory model 
may also not show evidence of R. felis infection in the blood. Also, mammals may simply be 
asymptomatic reservoirs. Further research with vertebrates, such as association with other R. 
felis-infected arthropods or contact with infectious arthropod feces, might aid in answering these 
questions and discovering a definitive, disease-causing transmission mechanism from arthropod 





CHAPTER 2: TRANSMISSION POTENTIAL OF RICKETTSIA FELIS TO 
VERTEBRATES VIA CUTANEOUS INOCULATION OF INFECTIOUS FLEA FECES 
2.1. Introduction 
Rickettsia felis is a gram-negative, intracellular bacterium of the transitional group 
Rickettsiae and the causative agent of flea-borne spotted fever [1]. Clinical presentations of this 
disease in humans vary widely, ranging from asymptomatic carriers in Africa [15, 16], to mild 
fevers and dermal lesions [4], to finally the most severe manifestations including pneumonia and 
neurologic signs [14]. Diagnosis of the disease has previously been through somewhat indirect 
methods, including PCR of both skin lesions [15] and blood from diseased individuals [4], as 
well as serology. However, the inability to isolate R. felis from the blood of acutely ill patients 
and lack of a definitive link between the organism and disease has led some to question the 
pathogenicity of the organism [16]. An alternative route to disease that does not include blood-
borne rickettsial organisms has been proposed, termed “yaaf,” after the Senegalese word for 
vesicle [15]. This suggestion is based on a case report from Africa where an infant girl erupted in 
vesicles and ulcers over her body and presented with a fever. While the cutaneous lesions from 
the girl were found to be PCR-positive for R. felis, blood samples were negative for the organism 
via PCR and no rickettsial antibodies were detected via serology (including IFA and western blot 
analysis). A similar case report from the Yucatán described an adult woman who presented with 
cutaneous lesions, along with fever, myalgia, and hearing loss. The skin lesions were PCR-
positive for R. felis, while blood samples showed no amplification of rickettsial genes. The 
patient also contained no detectable antibodies to Rickettsia in acute serum samples, but 
convalescent sera contained antibodies to R. akari, R. rickettsia, and R. typhi [19]. These reports 
suggest the possibility of a cutaneous manifestation of the disease that does not depend on a 
rickettsemic vertebrate host.  
14 
 
Adding to the perplexing nature of R. felis is the lack of a definitive transmission method 
between arthropod and vertebrates. The organism has been long believed to be transmitted to 
humans by the cat flea (Ctenocephalides felis) since its first isolation from a laboratory flea 
colony in 1992 [12]. Strong evidence for C. felis as the primary vector and reservoir of R. felis 
has been presented, including the finding of numerous R. felis-positive cat fleas in areas of 
human outbreaks of flea-borne rickettsiosis [5-7]. While R. felis has been demonstrated in cat 
flea salivary glands [28, 29], alternative routes of transmission other than arthropod bites, 
including transmission through infectious flea feces, remain to be investigated. Excretion of 
viable rickettsiae in feces of infected arthropods has been found to be crucial in the transmission 
for other related species, including Rickettsia prowazekii [38] and Rickettsia typhi [39, 40]. 
Additionally, previous work has demonstrated that potentially viable R. felis organisms are 
excreted in the feces by C. felis [22]. Thus, it was hypothesized that if cat fleas excrete viable R. 
felis after exposure to the organism, then the feces would be capable of producing infection in 
vertebrates through cutaneous inoculation. This study was undertaken to further investigate the 
presence of R. felis in infected cat flea feces and the role of these infectious flea feces in the 
transmission of R. felis to vertebrates. In this experiment, the feces of cat fleas previously 
exposed to R. felis-infected bloodmeals were examined for the presence of R. felis DNA and 
RNA. The potentially infectious flea feces were then intradermally inoculated into naïve 
BALB/c mice, and the effects of these feces were compared to R. felis-free feces, as well as to R. 
felis from culture, over a period of 14 days.  
15 
 
2.2. Materials & Methods 
2.2.1. Source and strains of bacteria, fleas, and mice 
The R. felis strain used was originally obtained from the Louisiana State University cat 
flea colony (LSU; passage 3) and maintained in Ixodes scapularis embryonic cell line (ISE6) in 
modified L15B growth medium as previously described [43]. Rickettsial infections within 
culture were monitored weekly using the Diff-Quik staining procedure [43]. Newly-emerged, 
Rickettsia-uninfected cat fleas were obtained from Elward II (El-Labs, Soquel, Ca). Five to ten-
week-old, mixed-sex, BALB/c mice were obtained from Louisiana State University (Division of 
Laboratory Animal Medicine) and used as a murine model organism.  
2.2.2. Ethics Statement 
This study was carried out in accordance with the following: Animal Welfare Act (9 CFR 
Ch. 1 Subpart C 2.31 (c) 1-8), Guide for the care and use of Agriculture Animals in Agricultural 
Research and Training (Chap. 1), and the Public Health Service Policy on Human Care and Use 
of Laboratory Animals (Section IV.B. (1-8)). All animal research was performed under the 
approval of the LSU Institutional Animal Care and Use Committee (IACUC; Protocol Number: 
15-115). 
2.2.3. Cat flea bloodmeal treatments in the artificial dog unit 
Cat fleas were pre-fed 3-4 days on uninfected, defibrinated bovine blood (HemoStat 
Laboratories, Dixon, CA) within an artificial dog unit as previously described [44]. Cat fleas 
were divided into cages of ~200 fleas each (mixed-sex). All flea cages were changed prior to 
exposure to either infectious or control bloodmeal. Prior to infection, a portion of cat fleas from 
each cage were tested via quantitative real-time polymerase chain reaction (qPCR) of the R. felis 
ompB gene [8] and determined to be R. felis-negative. Following 24 hours of pre-feeding with 
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heat-inactivated bovine blood, cat fleas were starved for 5-6 hours, and then given a Rickettsia 
felis-infected bloodmeal. To prepare the infectious bloodmeal, following enumeration by the 
BacLight viability staining kit (Molecular Probes, Carlsbad, CA), intact R. felis-infected ISE6 
cells (containing 5x109 rickettsiae) were pelleted by centrifugation at 13,000 x g for ten minutes, 
and then resuspended in 600 µL of HI bovine blood. Cat fleas were allowed to feed on the R. 
felis-infected bloodmeal for 48 hours, and then switched to an uninfected bloodmeal for the 
remainder of the study. To generate uninfected cat fleas and feces, 2 mL of unaltered (i.e. 
without rickettsiae) bovine blood was used as a control treatment. 
2.2.4. Collection of flea feces 
Following either exposure to infectious bloodmeals or control bloodmeals, cat flea cages 
were changed once every seven days for one month, at days 7, 14, 21, and 28-post exposure. 
Control cages were always changed before infected cages to avoid cross contamination. At the 
time of cage change, the remaining live cat fleas were collected and transferred to clean cages. A 
portion of the live cat fleas were collected for future qPCR analysis to determine presence of 
rickettsial infection. The dirty cages were inspected both grossly and under a dissection 
microscope to remove all dead cat fleas, larvae, and eggs, so only flea feces remained 
(“prepared” feces). Flea feces was then scraped from the cages, weighed, and kept in three 
separate microcentrifuge tubes for DNA extraction, RNA extraction, and extra for future mouse 
inoculations. Flea feces saved for DNA extraction was stored in 500 µL of sterile PBS and stored 
at -20°C. Flea feces saved for RNA extraction was stored in 1 mL of TRIzol and stored at -80°C. 
If flea feces was to be used for a vertebrate experiment, collection and qPCR analysis of feces 
was performed within 24 hours of experiment. While qPCR analysis was being performed, the 
extra flea feces was placed into a clean flea cage and put back into the artificial dog unit 
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overnight until the next day when the vertebrate experiment was performed (to ensure bacterial 
viability). All flea feces used for vertebrate experiments was taken from 14-days post-exposure 
to infectious bloodmeals for standardization of the inoculations mice received. 
2.2.5. Transmission experiments in BALB/c mice 
Eighteen (18) mixed-sex, 5 to 10-week-old BALB/c mice were used for each replicate of 
the vertebrate experiments (Figure 2). Fifteen (15) experimental mice were injected 
intradermally with either R. felis from culture (cell-free lysate) or R. felis-infected cat flea feces, 
mixed with warmed L15B total media, to a total volume of 100 µL. Three (3) control mice were 
injected with either L15B total media alone (as a control for R. felis from culture) or R. felis-free 
cat flea feces (as a control for R. felis-infected flea feces). Six (6) mice, including 5 experimental 
and 1 control, were sacrificed at each of the following time points: 24 hours post-injection, 48 
hours post-injection, and 14 days post injection. Mice that were kept for 14 days were monitored 
daily for any physical or clinical signs. Both experimental models, including injection of mice 
with R. felis from culture and R. felis-infected flea feces, included three replicates. For 
intradermal inoculations, both from culture and from feces, an infectious dose of 1x106 R. felis 
was calculated per mouse. The infectious dose was based on preliminary data using high passage 
R. felis (p. 8) [Legendre, Unpublished] where the average number of R. felis organisms per 
milligram of flea feces was found to be approximately 4x104. Given that cat fleas have been 
reported to produce ~0.77 mg of feces per day [45], an infective dose that aimed to mimic a 
natural infection was calculated based on the amount of feces that could be produced by five 
fleas living on a mouse for a week. Inoculations from R. felis from culture were enumerated via 
the backlight BacLight viability staining kit, and inoculations from infectious flea feces were 




Figure 2. Experimental methods for vertebrate inoculations 
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flea feces (confirmed via qPCR) mixed with L15B total media was used. For inoculations, mice 
were sedated with Isoflurane and a patch of hair was shaved in the intrascapular region. Mice 
were inoculated using a U-100 insulin syringe (Beckton, Dickinson and Company, Franklin 
Lakes, NJ). A sharpie marker was drawn around the resulting intradermal bleb to mark the site of 
inoculation (Figure 3).  
 
 
Figure 3. Intradermal inoculation of BALB/c mice. 
Site of intradermal inoculation on mice (red arrow), for both R. felis from culture and R. felis-
infected cat flea feces. A sharpie mark was utilized to delineate the inoculation site for future 
sample collection. 
 
Mice were kept in separate cages based on sex, and control mice were kept separated 
from experimental mice. As previously stated, mice were humanely euthanized with carbon 
dioxide at 24 hours, 48 hours, and 14 days post-injection. Blood was obtained via cardiac 
puncture and full necropsies were performed. Samples from skin both at the inoculation site (i.e. 
within the sharpie mark) and away from the inoculation site were aseptically collected and saved  
for DNA extraction (microcentrifuge tubes at -20°C), RNA extraction (1 mL of TRIzol at -
80°C), and histopathologic evaluation (biopsy cassettes in 10% formalin). Sections of heart, 
20 
 
spleen, and liver were also collected and saved for DNA extraction and histopathologic 
evaluation. 
2.2.6. Detection of Rickettsia felis in fleas, flea feces, and mice 
Previously collected fleas were surface sterilized prior to DNA extraction, via washing 
with 10% bleach for 5 minutes, 70% ethanol for 5 minutes, and finally sterile distilled water for 
5 minutes (three times). Fleas were then placed in separate 1.7 mL microcentrifuge tubes and 
crushed with sterile plastic pestles in a liquid nitrogen bath. Genomic DNA (gDNA) was 
extracted using Qiagen DNeasy Tisue Kit (Qiagen, Germantown, MD) according to the 
manufacterer’s instructions for tissue samples and eluted in 30 µL PCR-grade H20. For 
extractions from cat flea feces, a portion (10 mg) of “prepared” flea feces was mixed with 500 
µL of sterile PBS, followed by the standard protocol for extractions of non-nucleated blood 
according to the manufacturer’s instructions. For extraction from mouse tissue, tissue disruption 
and homogenization were performed by combining tissue samples with two sterile stainless-steel 
beads in a 1.7 mL Safe-Lock microcentrifuge tube containing proteinase K and Buffer ATL for 2 
cycles of 3 minutes at 30 Hz in a TissueLyser (Qiagen, Valencia, CA) [42], followed by the 
standard tissue extraction protocol according to the manufacturer’s instructions. A negative 
environmental control (DNA extraction reagents without a biologic sample) was utilized for each 
DNA extraction process. All gDNA preparations were stored at -20°C until further analysis was 
performed. Quantitative PCR for detection of the rickettsial ompB gene [8], the C. felis 18S 
rRNA gene [22], and mouse cfd gene [42] was performed. The qPCR was performed with a 
LightCycler 480 Real-Time PCR system (Roche), and results were presented as quantified 
rickettsial copy numbers per sample. For cat flea feces, the rickettsial copy number per sample 
was used to calculate the number of organisms per milligram of feces. For all results, if qPCR 
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results showed amplification very late in the cycle (> cycle 35), the amplified product was 
visualized on 1.5% agarose gel to obtain a band for confirmation. The bands were cut from the 
gel and purified using Wizard SV Gel and PCR Clean-Up System (Promega). Purified samples 
were submitted for sequencing by the dye terminator method on a 3130 Genetic Analyzer 
(Applied Biosystems) at LSU (School of Veterinary Medicine). Nucleotide similarities were 
compared using the GenBank database. Environmental controls and control mice were also 
subjected to the same process to ensure there was no contamination of samples. 
In order to examine the potential viability of R. felis found in both flea feces and mouse 
skin, rickettsial RNA was isolated from both “prepared” flea feces and mouse skin (both at and 
away from the inoculation sites), as previously described, with minor modifications [3]. 
Approximately 20 mg of “prepared” feces was combined with 1 mL of TRIZol, and mouse skin 
was combined with 1 mL of TRIZol and two stainless steel beads for tissue disruption and 
homogenization (as previously described with a TissueLyzer), prior to extraction. Extraction was 
performed using chloroform for phase separation, followed by removal of the aqueous phase 
(containing RNA), and finally RNA precipitation and wash with isopropanol and 75% ethanol, 
respectively. RNA samples were treated twice with DNase I (Promega) according to the 
manufacturer’s instruction, followed by RNA clean-up using RNA Clean & Concentrator (Zymo 
Research). The treated RNA samples were then used to synthesize cDNA, using iScript cDNA 
Synthesis Kit (Bio-Rad). To confirm the absence of DNA contamination, no-RT controls were 
included for all samples. Viability of the rickettsial organisms was determined via qPCR 
amplification of R. felis ompB from prepared cDNA samples.  
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2.2.7. Histopathology and Immunohistochemistry 
After formalin fixation, tissue samples were paraffin-embedded and sections were cut for 
both hematoxylin and eosin (H&E) staining and immunohistochemistry (IHC) with a polyclonal 
anti-Rickettsia antibody (diluted 1/1000) as previously described [42]. Tissue samples analyzed 
included any specimens that showed amplification of R. felis ompB via qPCR, as well as sections 
from control mice (inoculated with either culture media alone or R. felis-free cat flea feces). 
Samples were examined by a board-certified veterinary anatomical pathologist. The degree of 
dermatitis and panniculitis (inflammation of subcutaneous fat) were classified as either absent (0; 
no lesions noted), mild (+; rare to infrequent at high-power), moderate (++; change is found in 
multiple high-power fields or large foci are present in selected areas), marked (+++; changes are 
frequently observed in multiple high-power fields or change is severe in focal areas), or severe 
(++++, changes are similar to those seen in the previous category, with the addition of extensive 
necrosis). Any extensions into the superficial dermis, as well as the type of inflammatory cells 
present, were also noted. Immunohistochemistry samples were graded similarly: 0 (no rickettsial 
organisms seen), + (rare organisms seen), ++ (moderate numbers of organisms seen), and +++ 
(many organisms seen).  
2.2.8. Enzyme-linked immunosorbent assay (ELISA) on mouse sera 
Indirect ELISAs to detect anti-rickettsial IgG were performed on serum samples taken 
from mice sacrificed at 14 days post-injection as previously described, with minor modifications 
[31, 46].  Serum samples, mixed with blocking buffer (1% bovine serum albumin in 0.1% 
Tween-20) to a 1:32 dilution, were added to half of the wells of a 96-well R. parkeri antigen-
coated plate (Fuller Laboratories, Fullerton, CA). These dilutions were then added to the other 
half of the wells, containing 50 µL of blocking buffer, to obtain a 1:64 dilution. Serum from a 
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mouse previously inoculated with R. parkeri and wells without serum were used as positive and 
negative controls, respectively. After a 1-hour incubation, the plate was washed three times with 
washing buffer (0.1% Tween-20 in PBS). A secondary antibody (goat anti-mouse IgG 
conjugated to horseradish peroxidase diluted 1:1000 in blocking buffer) was added and allowed 
to incubate for 1 hour in the dark. Plates were then washed three times, followed by addition of 
the TMB Membrane Peroxidase Substrate (KPL, Gaithersburg, MD). After 30-40 minutes of 
incubation in the dark (time length depended on the color reached by the positive controls), the 
reaction was stopped with 2N sulfuric acid. Optical densities (ODs) were immediately read with 
a Spectramax M2 spectrophotometer (Molecular Devices, Sunnyvale, CA) at 450 nm minus the 
absorbance at 650 nm. Samples were run in duplicate and the mean ODs were calculated. 
Samples were considered positive if the mean of the net ODs was greater than the mean OD of 
the negative controls plus three standard deviations. 
2.2.9. Statistical Analysis 
All statistical analysis was performed using GraphPad Software (Prism 5 for Mac OS X, 
La Jolla, California). For all comparisons, a P-value of <0.05 was considered significantly 
different.  
2.3. Results 
2.3.1. Detection and Quantification of Rickettsia felis in cat flea feces 
Based on two replicates, all experimental cat fleas taken at all time points [7, 14, 21, and 
28 days post-exposure (DPE)] of the study were positive for R. felis genomic DNA (via qPCR 
amplification of R. felis ompB), depicting a 100% infection rate of cat fleas following exposure 
to an infectious bloodmeal. This infection was detected as early as 7 days post-exposure and 
remained for the entirety of the study (28 days post-exposure). No cat fleas from control cages 
24 
 
showed amplification of rickettsial DNA. Similarly, “prepared” flea feces taken from all time 
points from experimental cages was positive for R. felis genomic DNA, at varying rates (Table 
1). The overall mean from both replicates for all time points was 1.34x106 organisms per 
milligram of flea feces, with a range of 9.93x104 to 3.5x106 organisms per milligram of flea 
feces. The results from both trials were statistically analyzed to evaluate if there was a significant 
difference in the number of rickettsial organisms present in the flea feces at different time points 
(Figure 4). No significant differences were found via one-way ANOVA (P < 0.05) between any 
of the time points.  
 
 
Table 1. R. felis in infectious cat flea feces. 
 
FECAL SAMPLE R. FELIS DNA R. FELIS RNA 
7 DPE 4.02E5 (3.02E5 – 5.02E5) + 
14 DPE 1.5E6 (9.93E4 – 2.99E6) + 
21 DPE 1.26E6 (4.34E5 – 2.1E6) + 
28 DPE 2.19E6 (8.87E5 – 3.5E6) + 
DNA results shown in R. felis number of organisms per mg of feces (based on qPCR 
amplification of R. felis ompB). A “+” under RNA results indicates there was amplification of 
rickettsial cDNA prepared from isolated RNA samples. Data based on two replicates. 
 
To assess the viability of rickettsiae, and thus potential infectivity, the cat flea feces were 
analyzed for the presence of rickettsial transcripts. Flea feces collected at all time points in both 
replicates showed amplification of R. felis ompB from prepared cDNA, indicating that rickettsial 
transcripts, and potentially viable rickettsiae, were present at all time points (Table 1). The 
amount of rickettsial RNA was not assessed in this study. All no-RT samples were negative for 





Figure 4. Number of R. felis organisms present per milligram of flea feces. 
The data represents the number of organisms that are present per milligram of flea feces, based 
on qPCR results. Time periods represent days post-exposure (DPE) to infectious bloodmeal. No 
statistical differences were found between replicates. 
 
2.3.2. Detection of Rickettsia felis in mouse tissue 
For all three replicates, gDNA extractions were performed on all tissues (including skin 
at and away from the inoculation site, heart, liver, spleen, and blood) from 24- and 48-hours 
post-intradermal inoculation and were analyzed via qPCR for R. felis ompB amplification (Table 
2). For the mice injected with R. felis from culture, at 24- and 48-hours post inoculation, 68% 
(17/25) of skin samples taken from the inoculation site were positive for R. felis gDNA, while 
16% (4/25) of skin samples taken away from the inoculation site were positive. Two samples 
from the heart (8%) and one blood sample (4%) out of 25 also were qPCR-positive for R. felis 
ompB gene amplification. No liver or splenic samples taken from any time points were positive 
(0%; 0/25).  One of the gDNA extraction environmental controls for 1 time point (correlating to 
5 experimental mice at 24-hours post-inoculation) showed minor amplification of R. felis ompB, 
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and therefore the corresponding experimental mice were not included in any of the presented 
data. All other control mice and environmental controls were negative. For the mice injected 
with R. felis-infected flea feces, at 24- and 48-hours post injection, 33% (10/30) of skin samples 
taken from the inoculation site were positive, and 13% (4/30) of skin samples taken away from 
the inoculation site were positive. No liver, splenic, heart, or blood samples from any time points 
from mice injected with R. felis-infected flea feces were qPCR-positive for R. felis ompB gene 
amplification. No experimental controls or control mice were positive. All samples that showed 
late amplification (> cycle 35) were run on a gel to obtain a band for confirmation. Sequencing 
revealed 100% identity to the R. felis ompB gene (Ascension KX090279.1) for all samples that 
were considered positive. No bands were visualized for environmental controls or control mice.  
 
Table 2. Mouse samples positive for R. felis gDNA via qPCR. 
 
Tissue Samples positive for R. felis 
 R. felis from culture R. felis-infected feces 
Skin at inoculation site 17/25 (68%) 10/30 (33%) 
Skin away from inoculation site 4/25 (16%) 4/30 (13%) 
Heart 2/25 (8%) 0/30 (0%) 
Spleen 0/25 (0%) 0/30 (0%) 
Liver 0/25 (0%) 0/30 (0%) 
Blood 1/25 (4%) 0/30 (0%) 
Samples are from mice sacrificed at 24- and 48-hours post-intradermal inoculation. Data based 
on three replicates. All control mice (injected with either L15B total media or R. felis-free flea 





Detection of R. felis gDNA at the site of inoculation was significantly higher in mice 
injected with R. felis from culture compared to mice injected with R. felis-infected flea feces 
(unpaired t-test, P < 0.05). However, no statistically significant difference was found in R. felis 
qPCR detection in skin away from the inoculation site between experimental groups. 
The data presented represents three replicates of mice injected with R. felis-infected flea 
feces that was collected and analyzed within 24 hours of inoculation, while being maintained in 
the artificial dog unit until time of injection. The first trial (not included in the data) used 
previously frozen R. felis-infected flea feces. No tissue samples from any of the time points from 
this trial showed amplification of R. felis ompB via qPCR. This was presumed due to lack of 
bacterial viability (after freezing and thawing), so future experiments all used unfrozen, fresh 
“prepared” feces.  
To assess potential viability of the rickettsial organisms present, RNA isolation and 
cDNA synthesis, followed by amplification of R. felis ompB from cDNA, was performed on the 
skin samples that tested positive for R. felis gDNA via qPCR. No rickettsial transcripts were 
detected in any of the skin samples tested from 24- and 48-hours post-inoculation. 
2.3.3. Gross Pathology 
One mouse injected with R. felis from culture (at 48-hours post-injection) had a pinpoint, 
erythematous lesion at the injection site (Figure 5). This lesion did correlate with a skin sample 
that tested positive for R. felis gDNA via qPCR and IHC. All other tissues and all other 
necropsies on mice (including mice injected with R. felis from culture and R. felis-infected flea 
feces) were unremarkable (Figure 6). No mice developed any overt physical or clinical signs 





Figure 5. Pinpoint lesion on mouse infected with R. felis from culture. 
One mouse injected with R. felis from culture had a pinpoint, erythematous, scab-like lesion (red 
arrow) at the site of inoculation. This correlated with skin the tested positive for R. felis gDNA 




Figure 6. Representative photo of mouse skin post-intradermal inoculation. 
With one exception (shown in Figure 5), all mice showed no visible gross lesions at either 24 
hours, 48 hours, or 14 days post-intradermal inoculation with either R. felis from culture or R. 




2.3.4. Histopathology and Immunohistochemistry (IHC) 
All sections of tissue that showed amplification of rickettsial DNA via qPCR, including 
35 sections of skin and two sections of heart from mice sacrificed 24- and 48-hours post-
inoculation, were analyzed via histopathology and IHC. Control sections from corresponding 
tissues were also analyzed. For mice injected with R. felis from culture, histopathological 
evaluation revealed mild to occasionally moderate, deep dermatitis and panniculitis 
predominated by macrophages and lymphocytes, with lower numbers of neutrophils and rare 
plasma cells and mast cells (Figure 7). Some edema was also noted, and occasional inflammatory 
cells infiltrated the panniculus carnosus muscle (myositis). The control mice from this portion of 
study (that were injected with L15B total media alone) showed no histopathological changes. 
Using the scoring system as previously described, the mean histopathological score for mice 
injected with R. felis from culture (1.69+) was significantly greater than that of the control mice 
(0) at the inoculation site via an unpaired t-test (P < 0.05).  
Mice injected with R. felis-infected flea feces showed moderate to occasionally severe, 
suppurative deep dermatitis and panniculitis, with lower numbers of mononuclear cells. 
Extension into the muscle (myositis) was also occasionally seen. Few samples had focal to 
extensive liquefactive necrosis (Figure 8), characterized by pyknotic and karyorrhectic debris 
mixed with viable and degenerate neutrophils and extensive fibrin deposition.  Control mice 
from this portion of the study (that were injected with R. felis-free cat flea feces) showed similar 
histopathologic changes (Figure 9), with the exception of liquefactive necrosis, which was absent 
in the control sections. A significant difference was not found between the mean 
histopathological scores for experimental mice (2.37+) and control mice (3+). Compared to skin 




Figure 7. Histopathology of mouse skin post-inoculation with R. felis from culture. 
Photomicrographs of an H&E stained skin section taken from the site of inoculation (100x; Inset: 
400x). There is mild to moderate deep dermatitis and panniculitis, characterized by 
predominantly mononuclear cells (including macrophages and lymphocytes- depicted in the 
inset), with fewer neutrophils and scattered mast cells and plasma cells. There is also cell 




Figure 8. Histopathology of mouse skin post-inoculation with R. felis-infected flea feces. 
Photomicrographs of an H&E stained skin section of mouse tissue taken from the site of 
inoculation (100x; Inset 400x). There is severe suppurative dermatitis and panniculitis with 
liquefactive necrosis, characterized by a dense band subjacent to the panniculus carnosus of 






Figure 9. Histopathology of mouse skin post-inoculation with R. felis-free flea feces. 
Photomicrographs of an H&E stained skin section taken from the site of inoculation. A. (100x) 
Mice injected with R. felis-free flea feces showed moderate to marked, deep dermatitis and 
panniculitus, consisting predominantly of neutrophils (B- 400x), and fewer mononuclear cells. 
 
 
flea feces (2.37+) showed a greater histopathological score (unpaired t-test, P < 0.05). No 
histopathological changes were noted in any of the heart sections examined. 
For immunohistochemistry, only few samples showed rare positively staining 
coccobacilli (Figure 10). Three samples (3/25; 12%) of skin taken from the inoculation site from 
mice injected with R. felis from culture revealed rare organisms (+), and one sample (1/30; 3%) 
from the inoculation site from a mouse infected with R. felis-infected feces had rare organisms 
(+). The organisms were visualized both within macrophages and neutrophils, and occasionally 






Figure 10. Anti-Rickettsia immunohistochemistry of mouse skin post-inoculation with R. felis 
from culture. 
Photomicrographs of a skin section stained with a polyclonal anti-Rickettsia antibody. A: The 
skin sections revealed mild to moderate histiocytic to lymphocytic dermatitis (100x). B and C: 
Rare positive, brown-staining rickettsial organisms (red arrows) were seen within macrophages, 
neutrophils, and possibly the extracellular space (1000x; oil immersion). 
 
2.3.5. ELISA Results 
Serum from mice sacrificed at 14-days post-inoculation were analyzed via indirect 
ELISAs to detect the presence of rickettsial antibodies. At a 1:32 dilution, 8/10 (80%) mice 





only 1/9 (11%) of animals injected with R. felis from culture had detectable levels. At a 1:64 
dilution, only 2/10 (20%) of mice injected with R. felis-infected feces had detectable levels, and 
no mice with injected with R. felis from culture had measurable anti-Rickettsia IgG titers. Anti-
Rickettsia IgG was not detected in any control mice at significant levels (greater than 3 standard 
deviations above the mean ODs of the negative control). The number of mice with a measurable 
IgG response at a 1:32 dilution was significantly higher in the R. felis-infected feces group 


















CHAPTER 3: DISCUSSION & FUTURE DIRECTIONS 
In this study, cutaneous inoculation with feces from cat fleas infected with R. felis was 
found to be an effective transmission medium for the organism to mice, supported both by the 
detection of high numbers of viable rickettsiae in infected flea feces, as well as the presence of R. 
felis gDNA within the skin of mice inoculated with infectious feces. The response of these 
animals to intradermally injected R. felis-infected flea feces is characterized by primarily a 
neutrophilic dermatitis, as well as a positive anti-Rickettsia IgG response at 14 days post-
exposure. However, there were no physical or clinical changes associated with the transmission 
of R. felis through infectious cat flea feces, and no systemic dissemination of the organism was 
documented through this route. 
The first step in determining transmission of R. felis through infectious arthropod feces 
included confirming the presence of viable Rickettsia in cat flea feces. This study found that R. 
felis gDNA was present in high numbers in cat flea feces as early 7 days-post exposure (DPE) to 
an infectious bloodmeal and remained present for the rest of the experiment (up to 28 DPE). 
These findings confirm what was shown in a previous study where rickettsial gDNA was found 
in cat flea feces at all time points post-exposure to an infectious bloodmeal [22]. The average 
number of rickettsiae (based on qPCR amplification of the R. felis ompB gene) in this study was 
found to be 1.34x106 organisms per milligram of flea feces. This number is higher than what was 
found in a preliminary study (4x104 organisms/milligram) using high passage R. felis (LSU; 
passage 8) for cat flea infections [Legendre, Unpublished]. Because the data from the 
preliminary study was used in the calculation of the infectious dose for mice attempting to 
mimick a “natural” infection, it is possible that the dose used for inoculation of mice was 
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actually lower than what could be expected in nature. Future studies examining varying 
inoculation dosages might result in different findings in vertebrate inoculations.  
The presence of rickettsial transcripts within the cat flea feces at all time points, 
indicating potentially viable organisms, is a novel finding, as a previous experiment showed 
rickettsial transcripts were present only at 21 DPE [22]. This discrepancy is likely due to the 
advent of more sensitive RNA techniques that have developed since previous experiments were 
performed. Additionally, even though all time points had evidence of potentially viable R. felis 
organisms, there is the potential that feces taken from different DPE may have varying effects 
upon inoculation into vertebrates. This assumption is based on previous work done with R. typhi, 
where rats demonstrated seroconversion after intraperitoneal injection with flea feces only when 
the feces was obtained over 10 days post-flea infection [39]. For this reason, all vertebrate 
experiments were performed using feces taken from 14 DPE. This time point was chosen as 
opposed to 7 DPE because it has been suggested that early detection of R. felis gDNA in flea 
feces might be secondary to lysis of heavily infected midgut epithelial cells in fleas in early 
infection, as opposed to live, actively replicating, organisms [22, 23]. Later time points (i.e. 21 
DPE or 28 DPE) were not chosen for ease of experimental conditions. It is possible that the use 
of flea feces taken from varying time points post-exposure to an infectious bloodmeal may have 
produced different results in vertebrate inoculations.  
 Overall, R. felis from culture seemed to persist and possibly disseminate more efficiently 
in mice than R. felis within infectious flea feces. This is supported by the increased number of 
mice that had detectable levels of R. felis at the site of inoculation 24- and 48-hours post 
inoculation (68% compared to 33%), as well as the rare animals that had detectable levels of R. 
felis within the heart and blood when injected with R. felis from culture. While dissemination in 
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the animals injected with R. felis from culture could not be confirmed via staining of the 
organisms with IHC, it is suspected that the low number of bacteria present (detected via qPCR 
amplification) precluded immunohistochemical labeling, as IHC is not as sensitive as PCR for 
the detection of most organisms. The increased persistence and possible dissemination in the 
animals injected with R. felis from culture is likely due to a decreased immune response to the 
bacteria alone compared to the bacteria within flea feces. Mice injected with R. felis-infected flea 
feces exhibited a more severe cutaneous reaction (characterized by a moderate to severe 
suppurative dermatitis) compared to the mice injected with R. felis from culture. Additionally, a 
positive anti-Rickettsia IgG response (at a 1:32 dilution) was found more commonly in mice 
injected with R. felis-infected feces than R. felis from culture (80% vs. 20%, respectively). These 
findings suggest that the flea feces acted as a potential adjuvant and increased the animals’ 
immune responses to the injected bacteria, leading to an increased clearance and lack of 
dissemination.  
 The low numbers of organisms detected via qPCR amplification is also thought to be the 
reason that no rickettsial transcripts were found in the skin of mice injected with R. felis from 
culture or R. felis-infected flea feces. As RNA is much more difficult to extract and detect than 
DNA, our conclusion remains that viable rickettsiae were intradermally inoculated into the mice. 
This idea is supported by the fact that detection of R. felis gDNA in the skin of mice injected 
with R. felis-infected flea feces was precluded when the flea feces were previously frozen, 
corroborating the thought that only viable rickettsiae could persist in the skin within detectable 
limits of qPCR amplification for 24 to 48 hours. Future studies with a higher inoculation dose 
that would increase the levels of bacteria within the skin, and thus likely increase the chances of 
RNA detection, would help confirm this hypothesis. 
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BALB/c mice were chosen as a murine model organism for vertebrate inoculations based 
on the previous findings that this strain produced a detectable rickettsemia post-intraperitoneal 
injection with R. felis from culture [32]. BALB/c mice are particularly well known for their 
demonstration of Th2-biased immune responses [47]. Rickettsial bacteria are intracellular 
organisms which target endothelial cells and macrophages [48], and therefore primarily induce a 
Th1 immune response, requiring the generation of cytotoxic T lymphocytes for protective 
immunity. In this sense, BALB/c mice could possibly be immunodeficient in regards to 
rickettsial killing if they favor a Th2 response. This work is clearly a preliminary study, and 
future use of different vertebrates (including alternate strains of mice, other rodents, and even 
larger vertebrates) will likely produce varying results.  
 The lack of physical changes, especially at the site of cutaneous inoculation with R. felis 
–infected flea feces, was a surprising finding. However, the histologic changes noted in the skin 
of the injected mice were all deep within the dermis and underlying subcutaneous tissue, with no 
evidence of epidermal changes, which supports the lack of gross findings. An ideal animal model 
for studying a disease would mimic the physical and clinical signs observed in the human 
disease. However, given the wide range of described clinical presentations for human flea-borne 
spotted fever, it is difficult to accurately assess if an animal model is appropriate. It could be 
suggested that the response of the mice in this study injected intradermally with R. felis-infected 
flea feces most closely resembles the “yaaf” disease entity, supported by the amplification of R. 
felis gDNA from skin at the inoculation site and anti-Rickettsia IgG titers 14 days post-injection. 
However, these mice clearly lacked cutaneous lesions or any other systemic signs. While the 
most common reported accompanying symptom in humans was a fever, and mouse body 
temperatures were never assessed, mice never showed any clinical signs that warranted further 
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physical examination (e.g. ruffled fur, lethargy, squinted eyes). Lack of epidermal changes, and 
thus gross lesions, could be secondary to the route of inoculation (intradermal injections) of the 
infectious flea feces. Another cutaneous route of inoculation, such as introduction of infectious 
flea feces into open dermal wounds or puncture of the epidermis with an infectious flea feces-
laden object, could produce similar lesions to what is observed in the human disease. 
 Overall, this study shows that high numbers of viable rickettsiae are excreted in cat flea 
feces infected with R. felis. These viable bacteria, along with the flea feces, can be introduced 
into vertebrates via intradermal injection and produce a measurable response, consisting of a 
moderate to severe suppurative dermatitis and a positive anti-Rickettsia IgG titer. Future work 
with varying inoculation doses, additional vertebrate models, and alternative cutaneous infection 
routes may prove helpful in determining the role of these infectious arthropod feces in the 
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